Aster DM Healthcare Limited
All news and filings related to Aster DM Healthcare Limited.
View all news & filings- Medium impact
Aster DM Healthcare announces NCLT hearing for Quality Care India amalgamation on May 22
Aster DM Healthcare Limited's amalgamation with Quality Care India Limited is proceeding. A joint company petition hearing is scheduled for May 22, 2026, before the NCLT. Newspaper advertisements regarding this have been published.
Read the summary - Medium impact
Aster DM Healthcare declares interim dividend of ₹3/share; sets April 3 record date
Aster DM Healthcare declared an interim dividend of ₹3 per equity share for FY 2025-26. The record date for determining entitlement is April 03, 2026. The announcement details applicable TDS provisions for resident and non-resident shareholders.
Read the summary - Medium impact
Aster DM Healthcare declares interim dividend of ₹3/share for FY26; Record Date April 3
Aster DM Healthcare declared an interim dividend of ₹3 per share for FY26. The record date for this dividend is April 3, 2026. TDS will be applicable on the dividend payout. Shareholders must submit documents by April 6, 2026.
Read the summary - Medium impact
Aster DM Healthcare Declares Interim Dividend of ₹3 Per Share
Aster DM Healthcare declared an interim dividend of ₹3 per share for FY 2025-26. The record date is April 3, 2026, with payment within 30 days. TDS will be applicable.
Read the summary - Low impact
Aster DM Healthcare receives GST demand order of ₹72.91 Lakhs
Aster DM Healthcare received a GST demand order of ₹72.91 Lakhs for FY19-24, alleging non-payment of GST on insurance processing fees. The company believes there is no material financial impact and plans to appeal the order.
Read the summary - Low impact
Aster DM Healthcare to Meet Investors/Analysts on March 27, 2026
Aster DM Healthcare management will meet investors and analysts on March 27, 2026, in Bengaluru. The meeting is organized by ICICI Securities Limited and will be conducted in person. No unpublished price-sensitive information will be shared.
Read the summary - Low impact
Aster DM Healthcare: Trading Window Closed March 19, 2026, for Q4 FY26 Results
Aster DM Healthcare's trading window will close on March 19, 2026, for designated persons. The window will reopen 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026.
Read the summary - Low impact
Aster DM Healthcare Publishes Postal Ballot Notice in Newspapers
Aster DM Healthcare Limited has published its Notice of Postal Ballot in the Financial Express (English) and Andhra Jyothi (Telugu) newspapers. The notice is also available on the company's website. This action is to inform stakeholders and regulatory bodies.
Read the summary - Medium impact
Aster DM Healthcare: Kerala Nurse Strike Disrupts Operations, Court Intervenes
Aster DM Healthcare experienced operational disruptions in its Kerala hospitals due to a nurse strike starting March 9, 2026. The High Court of Kerala intervened on March 13, 2026, deferring the strike until March 19, 2026. The company incurred a revenue loss of ₹17.69 crore and anticipates a potential additional loss of ₹5.33 crore.
Read the summary - Medium impact
Aster DM Healthcare seeks shareholder approval for Dr. Moopen's reappointment and loan guarantees up to ₹1,500 Cr.
Aster DM Healthcare is seeking shareholder approval via postal ballot for the reappointment of Dr. Mandayapurath Azad Moopen as Executive Director and for granting loans or guarantees up to ₹1,500 crore to group entities. E-voting is open from March 14 to April 12, 2026.
Read the summary - High impact
Aster DM Healthcare gets strong shareholder and creditor vote for merger with QCIL
Aster DM Healthcare received overwhelming 96.68% shareholder and creditor approval for its merger with Quality Care India Limited (QCIL). The combined entity, Aster DM Quality Care Ltd, will be one of India's top three hospital chains with over 10,625 beds. The merger is expected to complete next quarter.
Read the summary - High impact
Aster DM Healthcare: Shareholders Approve Amalgamation Scheme
Aster DM Healthcare Limited shareholders approved the Scheme of Amalgamation with Quality Care India Limited. The NCLT-convened meeting held on March 10, 2026, saw overwhelming support for the amalgamation. The resolution passed with the requisite majority, including positive votes from public shareholders.
Read the summary - Medium impact
Aster DM Healthcare: Unsecured Trade Creditors Approve Amalgamation Scheme
Aster DM Healthcare's unsecured trade creditors approved the Scheme of Amalgamation on March 10, 2026. The resolution passed with 80.0693% of the debt value in favour. The meeting was conducted via video conference as directed by the NCLT.
Read the summary - Medium impact
Aster DM Healthcare Appoints Dr. Azad Moopen as Executive Director
Aster DM Healthcare's Board approved the appointment of Dr. Azad Moopen as Executive Director, effective April 15, 2026, until May 28, 2028. He will also continue as Chairman. This appointment requires shareholder approval via postal ballot.
Read the summary - Medium impact
Aster DM Healthcare: Unsecured Trade Creditors Meeting Held for Amalgamation Scheme
Aster DM Healthcare held a meeting of unsecured trade creditors on March 10, 2026, to approve a Scheme of Amalgamation with Quality Care India Limited. The meeting was convened as per NCLT directions. Voting was conducted electronically, and results will be announced soon.
Read the summary - Medium impact
Aster DM Healthcare Shareholders Approve Amalgamation Scheme
Aster DM Healthcare Limited shareholders met on March 10, 2026, to approve the Scheme of Amalgamation with Quality Care India Limited. The meeting, held via VC/OAVM, saw 64 members attend. Remote e-voting was conducted from March 6-9, 2026. The results will be disseminated shortly.
Read the summary - High impact
Aster DM Healthcare Shareholders Meeting on March 10 for Merger Approval
Aster DM Healthcare will hold a shareholder meeting on March 10, 2026, to approve the amalgamation scheme with Quality Care India Limited. The merger aims to create one of India's top 3 hospital chains, with potential EBITDA synergies of 10-15%. Remote e-voting is available from March 6-9, 2026.
Read the summary - Medium impact
Aster DM Healthcare Signs SHA with Subsidiary for CCPS Issuance
Aster DM Healthcare entered a Shareholders' Agreement (SHA) with its subsidiary, Aster DM Super-specialty Hospital (Sarjapur) Private Limited, on February 26, 2026. The agreement pertains to the issuance of Compulsorily Convertible Preference Shares (CCPS) by the subsidiary. It outlines governance, share transfer restrictions, and call option rights for Aster DM Healthcare.
Read the summary - Low impact
Aster DM Healthcare to Participate in IIFL Investor Conference on Feb 25
Aster DM Healthcare will participate in the IIFL Investor Conference on February 25, 2026. The event will include group and one-on-one meetings held physically in Mumbai from 10:00 AM to 5:00 PM IST. No unpublished price-sensitive information will be disclosed.
Read the summary - Low impact
Aster DM Healthcare to Participate in Kotak Investor Conference on Feb 24, 2026
Aster DM Healthcare will participate in the Kotak Investor Conference on February 24, 2026, in Mumbai. The event will include group and one-on-one meetings. The company confirmed that no unpublished price-sensitive information will be disclosed during the meetings.
Read the summary - Medium impact
Aster DM Healthcare Q3 FY26 Earnings Call Transcript Released
Aster DM Healthcare released its Q3 FY26 earnings call transcript. The combined proforma entity reported a 15% revenue growth to ₹2,366 crore and a 22% EBITDA increase to ₹503 crore. Aster's standalone revenue grew 13% to ₹1,186 crore. The merger with Quality Care India is progressing, with completion expected in Q1 FY27. Capacity expansion plans include adding over 4,000 beds.
Read the summary - Low impact
Aster DM Healthcare to Participate in Investor Conference on Feb 11, 2026
Aster DM Healthcare will participate in an investor conference on February 11, 2026. The event will include group and one-on-one meetings held physically in Mumbai from 10:00 AM to 5:00 PM IST. No unpublished price-sensitive information will be shared.
Read the summary - Medium impact
Aster DM Healthcare Shareholders' and Creditors' Meetings on March 10, 2026
Aster DM Healthcare Limited will hold meetings for Equity Shareholders and Unsecured Creditors on March 10, 2026, to approve the Scheme of Amalgamation with Quality Care India Limited. All meetings will be virtual, with remote e-voting available from March 6-9, 2026.
Read the summary - High impact
Aster DM Healthcare & Quality Care Merger to Form Top 3 Indian Hospital Chain
Aster DM Healthcare is merging with Quality Care India Limited to form a top 3 hospital chain in India with over 10,625 beds and ₹8,105 crore revenue. The merged entity will see Aster DM shareholders holding 57.3% stake. Q3FY26 proforma revenue reached ₹2,366 crore (15% YoY growth) and EBITDA ₹503 crore (22% YoY growth).
Read the summary - Medium impact
Aster DM Healthcare to hold Unsecured Trade Creditors Meeting on March 10, 2026 for Amalgamation Scheme
Aster DM Healthcare Limited will hold a meeting for Unsecured Trade Creditors on March 10, 2026, to approve the amalgamation scheme with Quality Care India Limited. Remote e-voting is available from March 6 to March 9, 2026. The cut-off date for voting eligibility is October 31, 2025.
Read the summary - Medium impact
Aster DM Healthcare Shareholder Meeting on March 10, 2026 for Amalgamation Scheme Approval
Aster DM Healthcare will hold a shareholder meeting on March 10, 2026, to approve the amalgamation scheme with Quality Care India Limited. Remote e-voting is open from March 6-9, 2026. The merger aims to enhance scale, financial metrics, and growth potential, with promoter shareholding expected to rise to 54.68%.
Read the summary - Low impact
Aster DM Healthcare Q3 FY26 Earnings Call Recording Available
Aster DM Healthcare's earnings call recording for Q3 FY26, covering the nine months ended December 31, 2025, is now available. The recording can be found on the company's investor website. The earnings call was held on January 02, 2026.
Read the summary - Low impact
Aster DM Healthcare to Meet Investors on Feb 5-6, 2026
Aster DM Healthcare will host investor meetings on February 5-6, 2026, in Mumbai. The meetings will be conducted physically, with one-on-one sessions scheduled on February 5th from 9 AM to 6 PM IST. No unpublished price-sensitive information will be disclosed.
Read the summary - Low impact
Aster DM Healthcare files newspaper clippings for Q3 FY26 results
Aster DM Healthcare has published newspaper clippings for its unaudited financial results for the quarter and nine months ended December 31, 2025. These results were approved by the Board on January 30, 2026, and published on January 31, 2026. The details are accessible via QR code and the company website.
Read the summary - Low impact
Aster DM Healthcare: Legal Head Prajwal Jaigopal Resigns Effective Jan 31, 2026
Prajwal Jaigopal, Legal Head at Aster DM Healthcare, has resigned due to personal commitments. His last day will be January 31, 2026. He has been with the company since July 21, 2023.
Read the summary - High impact
Aster DM Healthcare Q3FY26: Combined Revenue Rises 15% to ₹2,366 Cr
Aster DM Healthcare's combined entity reported Q3FY26 revenue of ₹2,366 crore, up 15% YoY, with patient volumes up 9%. EBITDA grew 22% to ₹503 crore. The company filed for NCLT approval for its merger, with shareholder meetings scheduled between Feb 27-Mar 13, 2026. Bed capacity increased to over 10,620.
Read the summary - High impact
Aster DM Healthcare Q3 FY26 Revenue Up 13% to ₹1,186 Cr; Combined Proforma Revenue Up 15% to ₹2,366 Cr
Aster DM Healthcare reported Q3 FY26 standalone revenue of ₹1,186 crore, up 13% YoY, with operating EBITDA up 17% to ₹237 crore. The combined proforma entity (Aster + QCIL) saw Q3 FY26 revenue rise 15% to ₹2,366 crore and operating EBITDA increase 22% to ₹503 crore. A shareholders' meeting for the merger is scheduled between Feb 27 and Mar 13, 2026, with completion expected by Q1 FY27.
Read the summary - Medium impact
Aster DM Healthcare Board Approves Q3 Results, ESOP Scheme, and Loan Conversion
Aster DM Healthcare's Board approved Q3 FY26 results. An inter-corporate loan of ₹129.35 crore will be converted into equity in a subsidiary. An ESOP Scheme 2026 was also approved, requiring shareholder consent. Statutory registers will be moved to the corporate office.
Read the summary - Medium impact
Aster DM Healthcare Board Approves Q3 FY26 Results & ESOP Scheme
Aster DM Healthcare approved Q3 FY26 results and the ESOP Scheme 2026. A ₹129.35 crore inter-corporate loan will be converted into equity in a subsidiary. Shareholder approval will be sought for the ESOP scheme and other corporate actions via postal ballot.
Read the summary - Medium impact
Aster DM Healthcare Board Approves Q3 Results, ESOP Scheme, and Subsidiary Restructuring
Aster DM Healthcare approved Q3 FY26 results. The board also approved the ESOP Scheme 2026 and a restructuring of Aster DM Multispecialty Hospital, converting a ₹129.35 crore loan into equity. Shareholder approval will be sought via postal ballot for these items.
Read the summary - Medium impact
Aster DM Healthcare to acquire 20.25% stake in Malabar Institute of Medical Sciences
Aster DM Healthcare approved acquiring an additional 20.25% stake in its subsidiary, Malabar Institute of Medical Sciences (MIMS), to reach 100% ownership. The acquisition is valued at ₹202 per share. MIMS reported ₹1,118.05 crore turnover and ₹134.51 crore profit as of March 31, 2025. The transaction is expected to conclude within three months of dispatching the offer letter.
Read the summary - Low impact
Aster DM Healthcare Schedules Q3 FY26 Earnings Conference Call for Feb 02, 2026
Aster DM Healthcare will hold its Q3 FY26 earnings conference call on February 2, 2026, at 11:00 AM IST to discuss financial results for the quarter and nine months ended December 31, 2025. Key management personnel will be present.
Read the summary - High impact
Aster DM Healthcare receives NCLT order for merger with Quality Care India Ltd
Aster DM Healthcare has received NCLT approval to convene shareholder and creditor meetings for its merger with Quality Care India Ltd. The meetings are scheduled between February 27, 2026, and March 13, 2026. The merger is expected to be completed by Q1 FY27, creating one of India's top three hospital chains with over 10,360 beds.
Read the summary - Medium impact
Aster DM Healthcare: NCLT directs meetings for Quality Care India amalgamation
The NCLT Hyderabad has ordered meetings for Aster DM Healthcare's equity shareholders and unsecured creditors regarding its amalgamation with Quality Care India. Meetings will be held between February 27 and March 13, 2026. Secured creditors' meetings have been dispensed with.
Read the summary - Low impact
Aster DM Healthcare: Nil Share Transfer Requests Processed in Dec 2025 - Jan 2026
Aster DM Healthcare reported nil share transfer requests received, processed, approved, or rejected for the period December 2025 to January 6, 2026. This update is in accordance with SEBI circular dated July 02, 2025, and was provided by the company's RTA, MUFG Intime India Private Limited.
Read the summary - Low impact
Aster DM Healthcare: Compliance Certificate for Q3 FY26 Filed
Aster DM Healthcare Limited filed a compliance certificate for Q3 FY26, confirming adherence to SEBI regulations regarding dematerialisation of securities. The certificate was issued by MUFG Intime India Private Limited for the quarter ended December 31, 2025.
Read the summary - Low impact
Aster DM Healthcare to host Investors/Analysts at Kochi & Trivandrum on Jan 8-9
Aster DM Healthcare will host investors and analysts for a hospital visit at Aster Medcity, Kochi, and QCIL KIMS, Trivandrum, on January 8-9, 2026. Management interactions will follow the visits. No unpublished price-sensitive information will be disclosed.
Read the summary - Medium impact
Aster DM Healthcare Increases Stake in Prerana Hospitals to 98.92%
Aster DM Healthcare acquired an additional 11.94% stake in Prerana Hospitals Limited on December 30, 2025, increasing its total holding to 98.92%. The remaining 1.08% is expected to be acquired by December 31, 2026. The acquisition cost was ₹38.36 crore.
Read the summary - Low impact
Aster DM Healthcare: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results
Aster DM Healthcare's trading window will close from January 1, 2026, for designated persons and their relatives. The window will reopen 48 hours after the declaration of Q3 FY26 financial results (standalone and consolidated). This is in compliance with SEBI regulations.
Read the summary - Low impact
Aster DM Healthcare Clarifies ₹125 Crore Kerala Project Subject to Board Approval
Aster DM Healthcare clarified its proposed ₹125 crore healthcare development project in Kottakkal, Kerala. The project is subject to obtaining necessary corporate approvals, including Board of Directors' consent. Further disclosures will be made upon approval.
Read the summary - Low impact
Submission of Monthly Report on Special Window Re-lodgement of Shares
Aster DM Healthcare submits its monthly report on the special window for re-lodgement of shares for November 2025, noting no requests were processed during the month as per SEBI guidelines.
Read the summary - Low impact
Aster DM Healthcare to attend Elara Capital's Bengaluru Corporate Day 2025
Aster DM Healthcare will participate in Elara Capital's “Bengaluru Corporate Day 2025” on 8th December, 2025 in Bengaluru for investor meetings.
Read the summary - Low impact
Aster DM Healthcare to attend Investor Conferences
Aster DM Healthcare will be participating in investor conferences on 26th and 27th November 2025.
Read the summary - Low impact
Aster DM Healthcare to participate in Investor Conferences
Aster DM Healthcare will participate in investor conferences on 26 and 27 November 2025. No unpublished price-sensitive information will be shared.
Read the summary - High impact
Aster DM Healthcare Investor Presentation - November 2025
Aster DM Healthcare releases investor presentation highlighting the merger with Quality Care, creating a leading hospital chain with 10,360+ beds. Q2 FY26 revenue at ₹1,197 Cr and EBITDA at ₹263 Cr.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio